Genotype-directed phase II study of irinotecan dosing in metastatic colorectal cancer (mCRC) patients receiving FOLFIRI + bevacizumab: The GENIC study
Abstract only
Saved in:
Published in: | Journal of clinical oncology Vol. 33; no. 15_suppl; p. TPS3621 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
20-05-2015
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.2015.33.15_suppl.tps3621 |